Skip to Content
Merck

B4388

2-Bromo-2-chloro-1,1,1-trifluoroethane

≥99%, Inhalation anesthetic, liquid

Synonym(s):

Halothane

Sign In to View Organizational & Contract Pricing.

Select a Size

125 ML

PLN 645.00

250 ML

PLN 1,830.00

PLN 645.00


Please contact Customer Service for Availability


About This Item

Linear Formula:
BrCH(Cl)CF3
CAS Number:
Molecular Weight:
197.38
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352202
EC Number:
205-796-5
MDL number:
Beilstein/REAXYS Number:
1736947

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

2-Bromo-2-chloro-1,1,1-trifluoroethane, ≥99%

InChI key

BCQZXOMGPXTTIC-UHFFFAOYSA-N

InChI

1S/C2HBrClF3/c3-1(4)2(5,6)7/h1H

SMILES string

FC(F)(F)C(Cl)Br

vapor pressure

4.5 psi ( 20 °C)

assay

≥99%

form

liquid

contains

0.01% thymol as stabilizer

refractive index

n20/D 1.369 (lit.)

bp

50.2 °C (lit.)

density

1.872 g/mL at 25 °C (lit.)

Quality Level

Looking for similar products? Visit Product Comparison Guide

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
CDS019345CDS020770649759
assay

≥99%

assay

-

assay

-

assay

97%

Quality Level

200

Quality Level

-

Quality Level

-

Quality Level

100

bp

50.2 °C (lit.)

bp

-

bp

-

bp

75-80 °C/15 mmHg

refractive index

n20/D 1.369 (lit.)

refractive index

-

refractive index

-

refractive index

n20/D 1.422

density

1.872 g/mL at 25 °C (lit.)

density

-

density

-

density

1.031 g/mL at 20 °C (lit.), 1.024 g/mL at 25 °C

form

liquid

form

solid

form

solid

form

-

Application

2-Bromo-2-chloro-1,1,1-trifluoroethane, or halothane, has been used in a study that combined molecular simulations with free energy simulations to study solvation of halothane in polarizable water and methanol. Halothane has also been used in a study to investigate the interaction of anesthetics with the Rho GTPase regulator Rho GDP dissociation inhibitor.

Biochem/physiol Actions

2-Bromo-2-chloro-1,1,1-trifluoroethane is an inhalation anesthetic. In an effect believed to be independent of anesthesia, halothane inhibits the synthesis of 5-hydroxytryptamine in brain tissue, probably at the tryptophan hydroxylase step.
Inhalation anesthetic.

signalword

Danger

Hazard Classifications

Eye Dam. 1 - Repr. 1B - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Mala Chakraborty et al.
Hepatology (Baltimore, Md.), 62(2), 546-557 (2015-02-26)
Clinical evidence suggests that many cases of serious idiosyncratic drug-induced liver injury are mediated by the adaptive immune system in response to hepatic drug-protein adducts, also referred to as "drug-induced allergic hepatitis"; but detailed mechanistic proof has remained elusive due
Samina Salim et al.
Behavioural brain research, 208(2), 545-552 (2010-01-13)
Recent work has suggested correlation of oxidative stress with anxiety-like behavior. There also is evidence for anxiolytic effects of physical exercise. However, a direct role of oxidative stress in anxiety is not clear and a protective role of physical exercise
G I Elmer et al.
Behavioural brain research, 359, 950-957 (2018-06-23)
A growing body of clinical and preclinical research suggests that structural and functional changes in the habenula, a component of the epithalamus, are associated with major depressive disorder. A major excitatory, efferent projection from the habenula targets the rostromedial tegmentum
Jason T Moore et al.
Current biology : CB, 22(21), 2008-2016 (2012-10-30)
Despite seventeen decades of continuous clinical use, the neuronal mechanisms through which volatile anesthetics act to produce unconsciousness remain obscure. One emerging possibility is that anesthetics exert their hypnotic effects by hijacking endogenous arousal circuits. A key sleep-promoting component of
T Russell et al.
Anaesthesia, 67(9), 1021-1024 (2012-06-28)
We present the case of a 20-year-old woman who developed rhabdomyolysis, disseminated intravascular coagulopathy and multi-organ failure induced by ecstasy. Following initial improvement, she developed delayed rhabdomyolysis then haloperidol-induced neuroleptic malignant syndrome, which was treated with a total of 50

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service